Body mass index does not affect the survival of pancreatic cancer patients
Qinglong Jiang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yingtai Chen(Shanghai Jiao Tong University), Yunmian Chu(Chinese Academy of Medical Sciences & Peking Union Medical College), Jie Ma(Tianjin University of Traditional Chinese Medicine), Dongbing Zhao(Chinese Academy of Medical Sciences & Peking Union Medical College), Jianwei Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Huang Huang(Fifth Affiliated Hospital of Zhengzhou University), Xu Che(Stomatology Hospital), Yuemin Sun(Chinese Academy of Medical Sciences & Peking Union Medical College), Wei Yuan(Chinese Academy of Medical Sciences & Peking Union Medical College), Yantao Tian(Chinese Academy of Medical Sciences & Peking Union Medical College), Shui-Sheng Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yawei Zhang(Yale University), Chengfeng Wang(Northeast Agricultural University)
Cited by 28
Related Papers
Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis
|Molecular Carcinogenesis|2010|558
Hepatitis C and Non-Hodgkin Lymphoma Among 4784 Cases and 6269 Controls From the International Lymphoma Epidemiology Consortium
|Clinical Gastroenterology and Hepatology|2008|336
Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations
|Nature Genetics|2011|198